MedPath

A Phase III Study of FYU-981 in Hyperuricemic Pediatric Patients with or without Gout (Extension Study)

Phase 3
Recruiting
Conditions
Hyperuricemic pediatric patients with or without gout
Registration Number
JPRN-jRCT2041220061
Lead Sponsor
Fushimi Masahiko
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Hyperuricemic pediatric patients with or without gout, who completed the observation for 30 weeks of Study FYU-981-018 (jRCT2031220036).

Exclusion Criteria

-Kidney calculi or clinically significant urinary calculi
-Patients deemed inappropriate by the investigator to conduct this study
etc.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath